Table 2.
Characteristics of Patients Experiencing Local Failure
| Age/Gender | Risk Stratum | Lesion | Prior Treatments | Technique | Dose (Gy) | Fractions | Concurrent Treatment | CR Achieved? | Time to Failure (months) |
|---|---|---|---|---|---|---|---|---|---|
| 51M | SS | Skin | none | electrons | 15 | 10 | none | no | 2.5 |
| 32M | SS | Skin | Multiple skin creams (inc. corticosteroids) | electrons | 31.5 | 21 | none | yes | 24.2 |
| 11F | MS/RO+ | Brain | VBL; thioguanine + MTX | conventional whole brain | 10.5 | 7 | none | no | 12.1 |
| 40F | SS | Brain | none | conventional | 10 | 5 | none | no | 4.7 |
| 61M | MS/RO− | Lymph Node | none | unknown | 50 | unknown | none | no | 11.3 |
CR: Complete Response; SS: Single System; MS: Multisystem; RO: Risk Organ; VBL: Vinblastine; MTX: methotrexate